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Abstract
Public health activities in the United States are delivered 
through  multiple  public  and  private  organizations  that 
vary widely in their resources, missions, and operations. 
Without strong coordination mechanisms, these delivery 
arrangements may perpetuate large gaps, inequities, and 
inefficiencies in public health activities. We examined evi-
dence and uncertainties concerning the use of partnerships 
to improve the performance of the public health system, 
with a special focus on partnerships between public health 
agencies and health care organizations. We found that the 
types of partnerships likely to have the largest and most 
direct effects on population health are among the most dif-
ficult, and therefore least prevalent, forms of collaboration. 
High opportunity costs and weak and diffuse participation 
incentives  hinder  partnerships  that  focus  on  expanding 
effective prevention programs and policies. Targeted policy 
actions and leadership strategies are required to illuminate 
and enhance partnership incentives.
Introduction
Public  health  activities  in  the  United  States  are   
implemented  through  the  combined  actions  of  multiple 
government and private organizations that vary widely in 
missions, resources, and operations. Public health agen-
cies serve as focal points, but these agencies rely heavily 
on their ability to inform and influence the work of oth-
ers. Public health delivery systems thus are complex and 
adaptive systems that operate through the interactions of 
multiple heterogeneous actors. Without strong coordina-
tion  mechanisms,  these  systems  may  perpetuate  large 
gaps and inequities in the availability and effectiveness 
of public health activities and substantial inefficiencies in 
performance (1). In other sectors, interorganizational part-
nerships and alliances have been used to coordinate action 
in ways that improve information flow, reduce duplication 
of effort, achieve economies of scale and scope, and acceler-
ate adoption of effective practices (2).
Recognizing  these  issues,  the  Institute  of  Medicine’s 
2003 review of the nation’s public health system called 
for “a new generation of intersectoral partnerships” that 
span the many different sectors of organizational activity 
that affect population health and that coordinate activities 
across these sectors (3). Partnerships that integrate medi-
cal care and public health approaches to achieve compre-
hensive health improvement are particularly important. 
In this article, we examine evidence, uncertainties, and 
emerging opportunities regarding the use of partnerships 
to improve the public health system.
Conceptual Framework: Partnerships as 
Collective Action
Public health partnerships are forms of collective action 
undertaken to promote health and prevent disease and 
injury in populations at risk. Collective action occurs when 
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organizations agree to coordinate activities in pursuit of 
shared objectives (4). Partnerships may benefit member 
organizations by allowing them to share information and 
expertise, human and material resources, or intangibles 
such as reputation, trust, and visibility. Partnerships may 
allow  organizations  to  combine  operations  and  realize 
economies of scope and scale in the production of public 
health services. Similarly, partnerships may allow coor-
dinated delivery of related programs and services, poten-
tially resulting in a larger combined impact on population 
health. In these ways, partnerships allow organizations to 
pursue objectives that may not be possible through inde-
pendent actions.
Partnership formation in public health depends on the 
range  of  organizations  available  in  a  given  community 
and the ability and willingness of each organization to 
contribute to public health activities (5,6). For some activ-
ities, economic incentives may encourage organizations to 
contribute voluntarily — such as the opportunity to gain 
revenue, reduce costs, or achieve visibility and recogni-
tion that confers a political or marketing advantage (7,8). 
Many organizations also may have noneconomic motives 
to  contribute,  such  as  an  altruistic  mission  to  improve 
health  and  social  welfare  (9).  Policy  and  regulatory 
actions,  such  as  the  requirement  that  tax-exempt  hos-
pitals meet community benefit standards, may motivate 
contributions.  Like  other  public  goods,  however,  public 
health activities may not generate sufficiently powerful 
incentives to ensure that they will be fully provided by 
voluntary action (10,11). In some cases, noncontributing 
organizations  benefit  from  the  public  health  activities 
performed by others, such as when health insurers realize 
cost savings from tobacco use cessation programs or vac-
cination programs (12). A traditional role for public health 
agencies is to directly provide beneficial activities that are 
underperformed by others, while also stimulating contri-
butions by other organizations to minimize unfair benefits 
(5). An agency’s success in these endeavors will influence 
partnership formation.
Concepts from behavioral economics suggest that collec-
tive actions may falter even when participation incentives 
are strong. Organizations often fail to value accurately the 
expected gains from collective action because of common 
decision  errors,  including  inconsistent  information,  risk 
aversion, mistrust, and tendencies to favor the status quo 
(11).  A  fundamental  challenge  for  public  health  profes-
sionals is to improve understanding of the expected value 
of partnerships among key stakeholders and to use policy 
and leadership strategies to enhance the incentives and 
blunt the disincentives for participation.
Current Evidence and Uncertainties About 
Partnerships
Partnership incentives
Partnerships provide a structure in which organizations 
can cooperate in producing activities designed to promote 
health and prevent disease and injury, but organizations 
will participate only if they have sufficient incentives. The 
perception of health care providers or payers that partici-
pation in a partnership will enhance revenues or reduce 
costs by increasing the reach and uptake of cost-effective 
prevention programs and services is an economic incen-
tive. However, the magnitude, distribution, and timing of 
such financial gains or cost savings are areas of consider-
able uncertainty and depend heavily on the nature and 
success of the partnership (13,14). Partnerships designed 
to  increase  the  reach  of  underused  but  highly  cost- 
effective clinical preventive services — such as smoking 
cessation,  influenza  vaccination,  aspirin  use,  colorectal 
cancer  screening,  or  family  planning  services  —  may 
reduce  future  medical  care  costs,  especially  if  the  part-
nerships  target  services  to  the  populations  at  risk  and 
allow implementation costs to be shared among multiple 
organizations (15,16). Similarly, partnerships designed to 
increase implementation of and compliance with nonclini-
cal public health programs and policies — such as smoking 
bans, seat belt laws, and environmental changes that pro-
mote nutrition and physical activity — may produce cost 
savings by reducing disease burden and the future need 
for medical care (17,18). Such partnerships for nonclinical 
interventions may have the added economic advantage of 
low implementation costs.
The  strength  of  economic  incentives  for  partnership 
formation depends not only on the magnitude of expected 
cost  savings  but  also  on  the  timing  and  distribution 
of  these  savings.  Partnerships  to  promote  colorectal 
screening, for example, involve time lags of a decade or 
more before cost savings from disease prevention can be 
expected, while partnerships that enhance tobacco control 
or vaccination coverage may generate a mix of short-term 
and longer-term savings. Time lags weaken the economic 
incentives for public health partnerships, especially for VOLUME 7: NO. 6
NOVEMBER 2010
  www.cdc.gov/pcd/issues/2010/nov/10_0088.htm • Centers for Disease Control and Prevention  
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the US Department of Health and Human Services, the 
Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and 
does not imply endorsement by any of the groups named above.
investor-owned organizations that operate under short-
term financial expectations and for employers and health 
insurers that experience turnover in their covered popu-
lations over time (19). Health care payers such as health 
insurers,  employers,  Medicare,  and  Medicaid  stand  to 
gain  most  directly  from  partnerships  that  enhance  the 
delivery  of  cost-effective  preventive  services  under  cur-
rent  payment  policies.  Some  physicians  and  hospitals 
may lose revenue as a result of public health partnerships 
that  reduce  medical  care  use  (20).  On  the  other  hand, 
some  providers  may  realize  savings  from  partnerships 
that target segments of the population that are uninsured 
and  would  otherwise  require  uncompensated  medical 
care. The expected distribution of these economic gains 
and losses in a community shape economic motivations 
for participating in partnerships.
Research  suggests  that  partnership  incentives  may 
depend partly on the size and market position of contribut-
ing organizations. Organizations that serve large segments 
of the community have strong incentives for partnership 
because they stand to gain large shares of any public goods 
produced through collective action (8,21). Small organiza-
tions may achieve economies of scale through partnerships 
by producing public health activities collaboratively that 
would be inefficient or unfeasible to produce independent-
ly (22). Organizations that fall between these 2 extremes 
may face diminished incentives.
Many organizations pursue public health partnerships 
primarily  for  noneconomic  reasons,  such  as  the  desire 
to  reach  new  target  populations,  expand  the  quantity 
or quality of services, and influence high-priority health 
issues. Noneconomic incentives often attract organizations 
with closely compatible missions, resulting in a preponder-
ance of government and nonprofit participants in many 
public health partnerships (5,8). Partnerships that include 
both economic and noneconomic incentives may appeal to 
other participants.
Partnership functions
Partnerships  provide  a  structure  for  accomplishing 
several  public  health  functions,  including  information 
exchange, planning and policy development, and imple-
mentation  of  programs  and  policies.  Partnerships  focus 
on information exchange by supporting surveillance, epi-
demiologic investigation, needs assessment, and research 
translation  activities.  Contemporary  examples  include 
sentinel provider networks for influenza, syndromic sur-
veillance  systems,  and  health  registries  such  as  those 
for  monitoring  cancer,  vaccination,  and  communicable 
diseases. More recently, some communities have formed 
partnerships to support the exchange of electronic health 
information for clinical decision making as well as public 
health surveillance and research. Research suggests that 
the quality of information generated through such part-
nerships depends partly on the nature of the relationships 
among participants (23).
Planning and policy development partnerships promote 
coordination and reduce duplication among organizations 
that otherwise work independently. Often these partner-
ships  form  as  a  result  of  communitywide  assessment 
and  performance  measurement  processes  that  identify 
unmet needs and opportunities for coordination, such as 
the  National  Association  of  County  and  City  Health 
Officials’  Mobilizing  for  Action  Through  Planning  and 
Partnerships program, or the Centers for Disease Control 
and  Prevention’s  National  Public  Health  Performance 
Standards  program.  In  some  cases,  these  partnerships 
also function as advocacy coalitions that develop and pro-
mote  policy  proposals  of  common  interest  (24).  Tobacco 
control coalitions are successful contemporary examples 
that work to secure smoking restrictions and tobacco tax 
increases in many states and communities.
Implementation partnerships bring organizations togeth-
er to collaborate in delivering public health interventions. 
The  focus  on  implementation  can  allow  these  partner-
ships to have more direct and immediate health effects 
than those focused exclusively on information exchange 
and  planning.  However,  the  success  of  these  endeavors 
hinges on their ability to focus on evidence-based interven-
tions, target interventions tightly to populations at risk, 
and pursue implementation on a sufficiently large scale 
(17,18,25,26). Success is likely to depend heavily on infor-
mation  exchange  and  planning  and  policy  development 
activities.  For  this  reason,  large-scale  implementation 
partnerships often develop only after other, prerequisite 
forms  of  collaboration  have  succeeded  (5).  Additionally, 
these partnerships may demand more human and finan-
cial resources and require more sacrifice of organizational 
autonomy and control than other forms of collaboration. 
Consequently, participating organizations may face sub-
stantial opportunity costs — alternative pursuits and indi-
vidual interests that must be sacrificed — to make these 
partnerships successful.VOLUME 7: NO. 6
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Some  of  the  most  successful  implementation  partner-
ships use external funding to diminish opportunity costs. 
Prominent examples include federally funded initiatives 
such  as  Steps  to  a  HealthierUS,  Racial  and  Ethnic 
Approaches to Community Health Across the U.S., and 
most recently Communities Putting Prevention to Work 
— all of which focus on preventing chronic diseases and 
reducing health disparities through community-level, mul-
tiorganizational  actions.  The  realities  of  high  operating 
costs but limited external funding mean that these types 
of  partnerships  reach  a  small  number  of  communities 
nationwide. Moreover, the time-limited nature of external 
funding creates uncertainties about long-term sustainabil-
ity of the partnership. Success in securing ongoing finan-
cial support and in expanding geographic reach depends 
heavily on the partnership’s entrepreneurship and ability 
to document health and economic gains (13).
Partnership composition and structure
Partnerships are social networks formed among organi-
zations; consequently, the substantial body of knowledge 
about  social  network  structure  helps  to  elucidate  these 
collaborations (27,28). Network breadth reflects the array 
of  different  actors,  which  determines  the  amount  and 
type of organizational resources that may be contributed. 
Network density measures the amount of interconnected-
ness between organizations, which facilitates their ability 
to work together. Network centrality reflects the relative 
influence of a single organization within a partnership, 
which can be important for coordinating and focusing col-
laborative actions. Both theory and research suggest that 
these constructs may influence partnership functioning, 
but their magnitudes and mechanisms of effect in public 
health are largely unknown.
Evidence  suggests  that  both  the  breadth  of  organiza-
tions contributing to public health activities and the scope 
of their participation has been increasing in recent years. 
A study of partnerships in US communities with at least 
100,000 residents found significant increases in the types 
of organizations that participate in public health activi-
ties from 1998 to 2006 (29,30). Not surprisingly, local and 
state government agencies were among the most frequent 
contributors to public health partnerships (Table), but hos-
pitals, physicians, community health centers, and univer-
sities significantly increased their participation over time.
Research  also  shows  that  public  health  partnerships 
generally adhere to 1 of 7 distinct structural configura-
tions based on network breadth, density, and centrality 
(Figure) (29,30). Three of these configurations support a 
broad  and  comprehensive  scope  of  public  health  activi-
ties, of which 1 configuration relies heavily on the work of 
government public health agencies and 2 others delegate 
considerable responsibility to other partner organizations. 
Two  partnership  configurations  deliver  an  intermediate 
(conventional) scope of public health activities and differ 
primarily in the centrality of the local public health agency 
in these activities. The final 2 configurations deliver a lim-
ited scope of public health activities and differ in both the 
centrality  and  density.  Partnerships  frequently  migrate 
from 1 configuration to another over time, with a trend 
toward supporting a broader scope of activities and engag-
ing a wider range of organizations.
 
 
Figure. Prevalence of 7 public health partnership configurations, 1998 and 
2006. Error bars represent 95% confidence intervals. Data were obtained 
from a survey of the 51 agencies that responded in both years (29,0). 
Seven configurations were identified through multivariate cluster analy-
sis, each one distinguished by network breadth, density, and centrality. 
Breadth represents the array of actors involved in the partnerships; density 
represents the amount of interconnectedness between organizations; and 
centrality represents the relative influence of a single organization within a 
partnership.
Recent  evidence  suggests  that  partnerships  operate 
somewhat  differently  in  small  and  rural  communities, 
where human and material resources are generally more 
limited. A recent network analysis of rural public health 
systems finds that smaller communities have fewer orga-
nizations  available  to  address  local  health  needs  and 
therefore  rely  more  heavily  on  the  local  public  health 
agency to play central roles (31). In larger rural commu-
nities, public health partnerships tend to fragment into VOLUME 7: NO. 6
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specialized collaborations, and the public health agency 
plays  more  peripheral  roles.  In  the  smallest  communi-
ties,  partnerships  achieve  more  density  when  the  local 
public  health  agency  operates  under  centralized  state 
governance,  but  in  larger  communities  decentralized 
governance  appears  to  foster  denser  partnerships,  per-
haps through enhanced autonomy and opportunities for 
entrepreneurship. These findings imply that partnership 
strategies should be tailored to the size of the community, 
the governance and legal environment for public health, 
and the types of activities to be undertaken through col-
lective  action.  Considerable  uncertainties  remain  about 
which partnership network structures work best in which 
public health settings.
Partnership outcomes and impact
Evidence  for  the  influence  of  public  health  partner-
ships on population health is limited but has grown in 
recent years alongside the larger evidence base support-
ing  population-based  disease  prevention  interventions 
(25). Measuring the effects of partnerships is complicated 
by the long time periods often required to change health 
behaviors and outcomes at a population level, the many 
confounding factors that simultaneously influence health 
endpoints of interest, and the fact that partnerships may 
have diffuse effects on multiple public health programs 
and  outcomes.  Nevertheless,  a  comprehensive  evidence 
review found that among 34 reviewed studies of public 
health  partnerships,  10  produced  evidence  of  improved 
population  health  outcomes  potentially  attributable  to 
partnerships,  including  such  outcomes  as  incidence  of 
lead  poisoning,  adolescent  pregnancy,  infant  mortality, 
and motor vehicle crashes (32). Another 14 studies found 
evidence of behavior change attributable to partnership 
activity in areas such as tobacco use, alcohol use, physical 
activity, and safe sexual practices. The strongest of these 
studies,  however,  suggested  that  the  effects  on  health 
behaviors may not be as large as intended (33). Another 
set of 22 studies suggested that partnerships generated 
beneficial changes in policies, programs, or environmen-
tal  conditions  such  as  the  adoption  of  smoking  bans, 
changes in school lunch menus, or the creation of exercise 
trails and community exercise groups (32). These types 
of partnership effects could be expected to produce popu-
lation  health  improvements  over  time  if  appropriately 
sustained.  However,  these  studies  relied  on  case  study 
research designs that could not establish definitively that 
observed changes were attributable to the partnerships. 
Nevertheless,  this  review  and  more  recent  studies  col-
lectively suggest that partnerships can produce beneficial 
outcomes under the right circumstances (34-36).
Evidence  concerning  the  economic  impact  and  cost- 
effectiveness  of  public  health  partnerships  is  an  area 
largely unaddressed in the empiric literature, as is the 
more  general  question  of  the  cost-effectiveness  of  com-
munity  preventive  services  (13,14).  Producing  this  evi-
dence  requires  measuring  the  direct  and  indirect  costs 
of participating in public health partnerships, including 
the opportunity costs that organizations incur. Obtaining 
valid  measures  of  such  costs  is  likely  to  require  the 
active  engagement  of  partnering  organizations  such  as 
through practice-based research networks and participa-
tory research methods. Such evidence is likely to be highly 
influential in shaping both government and private-sector 
decisions about contributing to partnerships.
Policy Implications and Future Prospects
A growing body of evidence and experience suggests that 
multiorganizational  partnerships  are  promising  mecha-
nisms for improving public health practice. However, the 
types of partnerships likely to have the most direct effects 
on population health are among the most difficult, and 
therefore  least  prevalent,  forms  of  collaboration.  These 
implementation  partnerships  are  those  that  focus  on 
expanding the reach of proven but underused interven-
tions  and  policies  through  collaboration  among  public 
health  agencies,  health  care  organizations,  and  other 
stakeholders. To succeed in improving population health, 
such  partnerships  must  target  programs  and  policies 
tightly to populations at risk, implement activities on a 
sufficiently large scale, and maintain fidelity to key pro-
gram and policy components over time. If successful, these 
partnerships can serve as vehicles for transforming public 
health practice from a diverse collection of activities and 
organizations into an organized and accountable delivery 
system for public health interventions.
Because  the  opportunity  costs  associated  with  these 
types  of  partnerships  are  high,  policy  and  administra-
tive  actions  are  needed  to  strengthen  the  incentives  for 
partnership formation. Better systems for measuring and 
reporting on the delivery of effective prevention programs 
and policies at the community level are needed to raise 
awareness  of  gaps  in  implementation  and  opportunities VOLUME 7: NO. 6
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for collaboration. Accreditation systems and performance 
standards that are being developed for government public 
health agencies can be tailored to create incentives for part-
nerships (37). Moreover, the 2010 federal health reform 
law creates opportunities for adapting both medical care 
and public health funding streams to reward partnerships 
that expand the implementation of effective but underused 
prevention  strategies.  Collectively,  these  changes  could 
serve as incremental steps along a path toward the more 
comprehensive pay-for-population health approaches that 
realign incentives for health improvement (38).
Beyond  incentives,  successful  partnerships  are  likely 
to require changes in organizational culture, values, and 
strategy that can be achieved only through strong orga-
nizational  leadership.  Partnerships  require  leaders  who 
can elucidate the participation incentives and constraints 
faced  by  individual  organizations  and  identify  shared 
objectives and compatible interests. Collaborative leader-
ship can reveal the potential gains from partnerships and 
help organizations commit to difficult but beneficial public 
health actions that cannot be accomplished through inde-
pendent endeavors.
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Table
Table. Partnerships Between Local Public Health Agencies and Selected Organizations, 1998 and 2006a
Type of Organization
Agencies Reporting Partnershipsb With Selected 
Organizations, 
N = 351 Scope of Activityc in Partnerships
1998, No. (%) 2006, No. (%) P Valued 1998, % 2006, % P Valuee
State government agencies  (98) 8 (99) .20 7 7 .01
Local government agencies 22 (92) 9 (97) .02 2 51 .001
Federal government agencies 155 () 215 (61) .001 7 12 .0
Physician organizations 299 (85) 25 (9) .006 20 2 .27
Hospitals 9 (97) 51 (100) .00 7 1 .0
Community health centers 179 (51) 297 (85) .001 12 29 .001
Nonprofit organizations  (95) 5 (95) .95 2  .60
Faith-based organizations NAf 286 (82) NC NAf 19 NC
Community-based organizations NAf 25 (9) NC NAf 2 NC
Health insurers 159 (5) 186 (5) .07 9 10 .57
Universities 20 (66) 275 (78) .001 16 22 .07
Schools NAf 15 (90) NC NAf 28 NC
Employers and business groups NAf 269 (77) NC NAf 17 NC
 
Abbreviations: NA, not assessed; NC, not calculated. 
a Data were obtained from a survey of all US local public health agencies that serve communities with at least 100,000 residents (29,0). These 97 agencies 
represent approximately 17% of all local public health agencies nationally but serve approximately 70% of the US population. Each agency was surveyed in the 
fall of 1998 (78% response rate) and again in the fall of 2006 (70% response rate). Data pertain to the 51 agencies that responded in both years. 
b Defined as participating in 1 or more of 20 core public health activities. 
c Defined as the mean proportion of activities undertaken through partnerships, based on a list of 20 core public health activities. 
d Calculated by using χ2 test. 
e Calculated by using equality of proportions test. 
f Data element was collected in 2006 only.